Skip to main content

Richard R. DeLuca

Equibles does not estimate personal net worth.

Get an email with a short summary when Merck & Co., Inc. publishes a filing, an earnings call transcript or a press release.

Get MRK alerts

About Richard R. DeLuca

The proxy statement of Merck & Co., Inc. reports total compensation of $9,098,531 for Richard R. DeLuca in fiscal 2024, including a base salary of $958,747. Disclosed compensation is on record for 6 fiscal years. Merck & Co., Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Merck & Co., Inc. includes Robert M. Davis (CEO, Chairman and Board Member), Jennifer Zachary (General Counsel), Dalton E. Smart III (Chief Accounting Officer) and 7 others.

Affiliation history

Company network

Leadership on record at Merck & Co., Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Merck & Co., Inc. (MRK) $958,747 $9,098,531
2023 Merck & Co., Inc. (MRK) $910,027 $6,197,890
2022 Merck & Co., Inc. (MRK) $840,522 $5,618,828
2021 Merck & Co., Inc. (MRK) $790,247 $6,841,000
2020 Merck & Co., Inc. (MRK) — —
2019 Merck & Co., Inc. (MRK) — —

Recent activity

No call appearances or filed executive changes recorded yet.